You're reading the free version. Trader adds the live tape and alerts.
Start tracking
APGE Disposition Disclosure
Henderson Jane · SEC Form 4 · Filed Sep 3, 2026
Disposition
Reported value range
Not reported
Henderson Jane Chief Financial Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Sep 3, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed same day
APGE daily price context
Close on/before transaction
$135.07
Sep 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 158,371 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001140361-26-035611
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE Current | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |